What was once a world of elves, dragons and power-ups is now giving rise to one of South Korea’s most unexpected tech revolutions, with game s...
BOSTON – Lotte Biologics Co. has signed a deal to manufacture an antibody therapy for British biotech startup Ottimo Pharma as the South Korea...
South Korea has finally agreed to reduce Indonesia’s contribution to their joint KF-21 fighter jet development project by two thirds to 600 bi...
Hanwha Q Cells Co., the solar panel manufacturing unit of South Korea's Hanwha Solutions Corp., is expected to commercialize tandem modules by 2027,...
Samsung Biologics Co., the world’s largest contract drugmaker, will undergo a strategic split to separate its contract development and manufac...
Rznomics Inc., a South Korean RNA therapeutics developer, has signed an agreement worth more than $1.3 billion with US pharmaceutical giant Eli Lill...
South Korea has officially requested that the US take a distinct approach in its ongoing probe into foreign semiconductor technology and related dow...
South Korea’s leading biosimilar drug developer Celltrion Inc. on Sunday unveiled an anticancer medicine to expand new pipelines and accelerat...
SK Hynix Inc., the leading global high-bandwidth memory (HBM) chip provider, has moved faster than its rivals in the commercialization of the next-g...
South Korea’s biopharmaceutical giant Celltrion Inc. has solidified its presence in South America after winning supply contracts for its flags...
Celltrion Inc. said Wednesday it has received regulatory approval from Australia’s Therapeutic Goods Administration (TGA) for three biosimilar...
Samsung Heavy Industries Co., a major Korean shipbuilder, has made a breakthrough in its liquefaction technology for floating liquefied natural gas ...
South Korea’s leading biosimilar drug developer Celltrion Inc. said on Monday it is set to sell Steqeyma, a biosimilar to autoimmune disease t...
South Korean biotechnology firm SillaJen Inc. is pioneering a new approach to determine the best dose for a cancer drug combination in clinical tria...
South Korea’s Samsung E&A Co. has purchased a stake in Norway’s hydrogen technology company Nel ASA at 47.6 billion won ($32.8 milli...
Samsung Bioepis Co. and Celltrion Inc. are outpacing long-established global drug manufacturers such as Amgen Inc. and Sandoz in the antibody biosim...
Chung Kisun, executive vice chairman of the world’s largest shipbuilder HD Hyundai Co., has met with Alex Karp, CEO of Palantir Technologies I...
Chong Kun Dang Pharmaceutical Corp. is discussing building a research center and a plant in Siheung, about 30 kilometers southwest of Seoul, with th...
South Korea’s Hyundai Rotem Co. said on Wednesday it has won a 2.2 trillion won ($1.5 billion) train order from Morocco, the biggest single de...
Celltrion Inc.’s Avtozma, a biosimilar to Roche’s autoimmune disease treatment Actemra, has won approval from the European Commission, f...
South Korea’s seven major defense companies saw their combined order backlog reach a record 105.6 trillion won ($73.1 billion) at the end of 2...
EQT, the largest private equity firm in Europe, is setting its sights on healthcare, technology companies and business service providers in South Ko...
SAN FRANCISCO -- Lotte Biologics Co., the drug consignment development and production unit of South Korean conglomerate Lotte Group, will seek to wi...
SAN FRANCISCO – South Korea’s leading biosimilar drug developer Celltrion Inc. seeks to acquire a domestic health food maker as early as...
South Korea’s SK Biopharmaceuticals Co. has signed a deal with Brazil’s Eurofarma Laboratórios S.A. to establish a joint venture ...
LAS VEGAS -- Hyundai Mobis Co., the world’s fifth-largest auto parts maker, plans to beef up its US production to cope with President-elect Do...
LAS VEGAS – South Korea’s top home appliance maker LG Electronics Inc. has thrown down the gauntlet to frontrunners in the AI robot race...
Hyundai Motor Group will invest 24.3 trillion won ($16.7 billion) this year in South Korea, the largest-ever annual investment in its home country, ...
Leclaza (ingredient: lazertinib), a new lung cancer treatment developed by South Korea’s Yuhan Corp. secured approval from the European Commis...
South Korea's Hyundai AutoEver Corp. said on Monday it built the joint venture PT Terra Link technology in Indonesia with India's MapmyIndia. T...
